Therefore, sourcing natural products that can effectively inhibit the NOX2, NF-κβ, and mdm2 proteins may be a worthwhile strategy for the identification of ROS, inflammation, and cancer drug candidates, respectively. Here, NFKB1 is linked to cancer.